Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2018
DOI: 10.1200/jgo.17.00082
|View full text |Cite
|
Sign up to set email alerts
|

Establishing Cancer Treatment Programs in Resource-Limited Settings: Lessons Learned From Guatemala, Rwanda, and Vietnam

Abstract: PurposeThe global burden of cancer is slated to reach 21.4 million new cases in 2030 alone, and the majority of those cases occur in under-resourced settings. Formidable changes to health care delivery systems must occur to meet this demand. Although significant policy advances have been made and documented at the international level, less is known about the efforts to create national systems to combat cancer in such settings.MethodsWith case reports and data from authors who are clinicians and policymakers in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
16
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(16 citation statements)
references
References 34 publications
0
16
0
Order By: Relevance
“…In 2018, 9.6 million lives were lost to cancer of which over 70% occurred in low and middle-income countries (LMICs) where limited access to cancer care and overwhelming late disease presentations negatively impact cancer related survival and quality of life [ 1 ]. Moreover, globally, new cancer cases are expected to increase from 18.1 million in 2018 to 21.4 million by 2030 [ 2 ]. In settings of poor health care systems and impoverished communities, the scarcity of and limited access to diagnostic and treatment modalities negatively impacts health outcomes and undermines achievement of the universal health care coverage (UHC) targets.…”
mentioning
confidence: 99%
“…In 2018, 9.6 million lives were lost to cancer of which over 70% occurred in low and middle-income countries (LMICs) where limited access to cancer care and overwhelming late disease presentations negatively impact cancer related survival and quality of life [ 1 ]. Moreover, globally, new cancer cases are expected to increase from 18.1 million in 2018 to 21.4 million by 2030 [ 2 ]. In settings of poor health care systems and impoverished communities, the scarcity of and limited access to diagnostic and treatment modalities negatively impacts health outcomes and undermines achievement of the universal health care coverage (UHC) targets.…”
mentioning
confidence: 99%
“…Financing for cancer-specific services and infrastructures, especially in the public sector and with other competing disease priorities, is often a challenge for already severely constrained national health care budgets. External financing efforts, including through multilateral or bilateral donor initiatives 277,278 and philanthropic/nonprofit sector investments, 279 have been critical to augment and expand nascent efforts by in-country agencies, although ensuring the sustainability of such approaches over the long term remains an ongoing challenge. 280 Rwanda is an illustrative example of both the successes and challenges of cervical cancer prevention and control in LMICs.…”
Section: Barriers To Implementationmentioning
confidence: 99%
“…The steps involved included training relevant staff in Nepal and allowing for Nepalese providers to receive training at UIC, exchange of standard operating procedures, overseeing construction of HCT unit in a Nepalese hospital, and continued teleconferences between UIC and Nepal. Another example includes enhancing cancer care in low-income limited resource countries such as Guatemala, Vietnam, and Rwanda [6]. Through partnership with established cancer centers and with significant investment, improvements, and development of infrastructure, training of relevant professionals, implementing new cancer screening programs, and developing cancer-specific health policy have improved cancer care in these regions.…”
Section: Development Of New Cancer-specific Programsmentioning
confidence: 99%